Nannette E Crowell, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2131 Hospital Dr, Sedro Woolley, WA 98284 Phone: 360-416-6735 |
Dan Siapco, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2131 Hospital Dr, Sedro Woolley, WA 98284 Phone: 360-416-6735 |
News Archive
Working with patients with electrodes implanted in their brains, researchers at the University of California, Davis, and The University of Texas Health Science Center at Houston (UTHealth) have shown for the first time that areas of the brain work together at the same time to recall memories. The unique approach promises new insights into how we remember details of time and place.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes. The assessment of the new dossier according to the German Act on the Reform of the Market for Medicinal Products (AMNOG) again showed that no added benefit of the drug over the appropriate comparator therapy (ACT) can be determined, because the pharmaceutical company has not submitted any relevant studies.
Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.
Shoghag Panjarian, PhD, a research scientist at the Coriell Institute for Medical Research, has been awarded a grant from the W. W. Smith Charitable Trust to support her search for epigenetic factors that contribute to the development and growth of breast cancer.
The old adage "never let them see you sweat," doesn't apply in the electrical and computer engineering lab of Rose Faghih, assistant professor of electrical and computer engineering in the University of Houston Cullen College of Engineering.
› Verified 3 days ago